Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant greater » significantly greater (Expand Search), significant gender (Expand Search), significant broader (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
Showing 81 - 100 results of 1,367 for search '(( significant decrease decrease ) OR ( significant greater decrease ))~', query time: 0.22s Refine Results
  1. 81
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 82
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 83
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 86
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 88
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 89
    Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts.

    Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 90
    Epac activation increased MYPT phosphorylation via PLC/PKC.

    Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 91
    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function.

    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 92
    Functional characterization of skinned myocardium prepared from Epac1TG.

    Functional characterization of skinned myocardium prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 93
    Epac activation increased RLC phosphorylation via PLC/PKC.

    Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 94
    Phosphorylation status of myofilament proteins prepared from Epac1TG.

    Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 95
    Effects of chronic ISO infusion on cardiac function in Epac1TG.

    Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Epac1 expression in the hearts of NTG and Epac1TG.

    Epac1 expression in the hearts of NTG and Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 97
    Evolution of health burden and life expectancy under different expenditure scenarios.

    Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 98
    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growth rate of fraction of GDP allocated to health (<i><i>f</i></i><sub>HE</sub>) assumed, leading to a yearly expenditure growth per scenario of [(1 + <i><i>g</i></i><sub>GDP</sub>) × (1 + <i><i>g</i></i><sub>fHE</sub>) − 1]. The normalised health expenditure (NHE) associated with each scenario (defined in

    Capabilities expansion scenarios considered. <i><i>g</i></i><sub>GDP</sub> and <i><i>g</i></i><sub>fHE</sub> refer to the growth rate of annual GDP (in constant 2015 US$) and growt... by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    Scaling of overall health burden with yearly expenditure growth.

    Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 100
    Impact on different areas of health.

    Impact on different areas of health. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: